Melanosis Coli: Case Report
PDF
Cite
Share
Request
Case Report
VOLUME: 29 ISSUE: 4
P: 201 - 203
December 2019

Melanosis Coli: Case Report

Turk J Colorectal Dis 2019;29(4):201-203
1. İstanbul Okmeydanı Training and Research Hospital, Clinic of Pathology, İstanbul, Turkey
2. İstanbul Kartal Dr. Lütfi Kırdar Kartal Training and Research Hospital, Clinic of General Surgery, İstanbul, Turkey
No information available.
No information available
Received Date: 07.09.2019
Accepted Date: 13.09.2019
Publish Date: 31.12.2019
PDF
Cite
Share
Request

ABSTRACT

Melanosis coli is an incidental benign finding characterized by the deposition of dark brown pigment in the colonic mucosa. The cause of this situation is due to long-term laxative use. We report a female patient who underwent surgery for colon adenocarcinoma and diagnosed as melanosis coli during histopathological examination.

Keywords:
Colon, melanosis coli, tumor

Introduction

Melanosis coli is characterized by increased macrophages localized in the colonic mucosa, with black-brown pigment in their cytoplasm. It is asymptomatic and is often incidentally detected during colonoscopic or histopathological examination.1 Histochemically, the intracellular pigment cross-reacts with Fontana-Masson and is lipofuscin-like. Ultrastructural studies have shown that this pigment is formed by the destruction of apoptotic colonic epithelial cells.2 Melanosis coli is detected during the investigation of the causes of constipation due to malnutrition especially in the elderly. Recently, the incidence has increased as a result of colonoscopic examinations.1,3

Discussion

Although there is no clear information about the incidence of melanosis coli, rates ranging from 1-59.5% have been reported.4,5 It is more common in women as in our case and in older age.1,6 Pigment can be observed more intensively in the cecum and ascending colon than in the distal column.1,2 In our case, melanosis coli was detected in the sigmoid colon. The use of laxatives, especially laxatives containing anthraquinone, is a well-known cause for melanosis coli. It can usually develop after 4-9 months of use. With the discontinuation of use, it may recede within months.7 It can be seen in varying rates in inflammatory bowel disease, colonic diverticulum, chronic diarrhea, non-steroidal anti-inflammatory drug use, colorectal polyps and tumors.5,8 It has been reported in the literature that it is frequently associated with colonic polyps.5,9 In one study, it was emphasized that pigment-free polyps were more easily detected in endoscopic examination because of the black-brown color of the mucosa.5 These polyps may include adenomatous polyps, which may include carcinoma focus. Biopsy from the non-pigmented areas in the recognition and exclusion of these lesions is also among the recommendations.10 In a study that reported the association with non-neoplastic polyps that contain pigment, the toxic effect resulting in the destruction of the apoptotic colonic epithelial cells was claimed to cause the development of the colorectal polyps, as well as melanosis coli.8 Although no polyp was detected in our case, it was observed that there was no macroscopic and microscopic pigment accumulation in ulcerated tumor tissue in accordance with the literature. Diffuse black-brown pigment was observed on the mucosa and serosal surface of the tumor proximal. Melanosis coli is a benign and reversible lesion. However, the findings in the studies on whether there is a relationship between colorectal tumors seen in similar age groups are controversial. In some of the studies, an increased risk for the tumor was reported in cases with melanosis coli, while some did not suggest a relationship.6,9 In conclusion, as in our case, melanosis coli can be defined as a lesion that may arise as a result of long-term laxative use in order to correct the changing bowel habit due to tumor.

References

1
Nesheiwat Z, Al Nasser Y. Melanosis Coli. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019.
2
Freeman HJ. ‘’Melanosis’’ in the small and large intestine. World J Gastroenterol 2008;14:4296-4299.
3
Ahasan HN, Khan MA, Mahbub S, Alam MB, Miah MT, Gupta RD, et al. Melanosis Coli - An Atypical Presentation. J Medicine 2010;11:183-185.
4
Biernacka-Wawrzonek D, Stepka M, Tomaszewska A, Ehrmann-Josko A, Chojnowska N, Zemlak M, et al. Melanosis coli in patients with colon cancer. Prz Gastroenterol 2017;12:22-27.
5
Wang S, Wang Z, Peng L, Zhang X1, Li J, Yang Y, Hu B, et al. Gender, age, and concomitant diseases of melanosis coli in China: a multicenter study of 6,090 cases. PeerJ 2018;6:e4483.
6
Siegers CP, von Hertzberg-Lottin E, Otte M, Schneider B. Anthranoid laxative abuse-a risk for colorectal cancer? Gut 1993;34:1099-1101.
7
Van Gorkom BAP, DeVries EGE, Karrenbeld A, Kleibeuker JH. Anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther 1999;13:443-452.
8
Liu ZH, Foo DCC, Law WL, Chan FSY, Fan JKM, Peng JS. Melanosis coli: Harmless pigmentation? A case-control retrospective study of 657 cases. PLoS One 2017;12:e0186668.
9
Nusko G, Schneider B, Ernst H, Wittekind C, Hahn EG. Melanozis coli-a harmless pigmentation or a precancerous condition? Z Gastroenterol 1997;35:313-318.
10
Abu Baker F, Mari A, Feldman D, Suki M, Gal O, Kopelman Y. Melanosis Coli: A Helpful Contrast Effect or a Harmful Pigmentation? Clin Med Insights Gastroenterol 2018;11:1-5.